Automated Analyzers Market 2025

Automated Analyzers Market Size

The global automated analyzers market reached a value of nearly $5,018.45 million in 2024, having grown at a compound annual growth rate (CAGR) of 8.15% since 2019. The market is expected to grow from $5,018.45 million in 2024 to $7,329.13 million in 2029 at a rate of 7.87%. The market is then expected to grow at a CAGR of 7.16% from 2029 and reach $10,354.19 million in 2034. Growth in the historic period resulted from favorable government support, shift toward personalized medicine, growth in healthcare infrastructure and increasing medical tourism. Factors that negatively affected growth in the historic period were the high costs of EMR systems and reluctance to adopt new technology in patients. Going forward, the increasing prevalence of chronic diseases, rising healthcare spending, expansion of telehealth services and increasing digital transformation in healthcare support will drive growth. Factor that could hinder the growth of the automated analyzers market in the future include were limited availability of skilled professionals and inadequate IT infrastructure.

Automated Analyzers Market Drivers

The key drivers of the automated analyzers market include: Increasing Prevalence of Chronic Diseases The increasing prevalence of chronic diseases is expected to be a key driver of the growth of the automated analyzers market in the forecast period. Automated analyzers deliver fast, precise and high-volume diagnostic testing, playing a critical role in chronic disease management and monitoring. With healthcare systems prioritizing early detection and continuous monitoring, these technologies drive operational efficiency and improve patient care. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of chronic diseases will drive demand for the automated analyzers market going forward.

Automated Analyzers Market Restraints

The key restraints on the automated analyzers market include: Lack of Skilled Personnel The lack of skilled personnel is expected to limit the growth of the automated analyzers market in the forecast period. The shortage of skilled personnel poses a challenge to the growth of automated analyzers, impacting their operation, maintenance and result interpretation. Without trained professionals, healthcare facilities may face difficulties in optimizing efficiency and accuracy, leading to underutilization of these advanced systems. For example, according to Gilson Incorporated, a US-based provider of liquid handling, purification and extraction products and consumables for the laboratory market, in Europe and the United Kingdom, the combination of a shortage of skilled lab workers and an aging workforce could result in a deficit of 700,000 technicians by 2030. Therefore, a lack of skilled personnel may hinder the growth of the automated analyzers market.

Automated Analyzers Market Trends

Major trends shaping the automated analyzers market include: Introduction of High-throughput Analyzer with Smart Testing Prioritization for Faster and More Accurate Results Major companies operating in the automated analyzers market are focusing on the development of high-throughput analyzers with smart testing prioritization for faster and more accurate results. This smart testing solution supports connectivity with laboratory information systems (LIS), facilitating seamless data management and reporting that optimizes workflow, reduces manual intervention and minimizes the risk of human error. For instance, in March 2025, Beckman Coulter, a US-based company that develops, manufactures and markets products relevant to biomedical testing announced that its DxC 500i Clinical Analyzer received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This integrated clinical chemistry and immunoassay system automates the process and is designed for laboratories of all sizes, featuring a throughput of up to 800 clinical chemistry tests and 100 immunoassay tests per hour. The analyzer incorporates advanced technology with an intuitive user interface, prioritizing testing based on sample urgency and optimizing workflow efficiency with its dynamic sample handler. Transforming Laboratory Efficiency with Smart Blood Analyzers Leading companies in the automated analyzers market are focusing on transforming laboratory efficiency with smart blood analyzers. This analyzer allows real-time monitoring, remote diagnostics and automated data transfer, reducing manual entry errors and improving workflow efficiency. For instance, in June 2024, HORIBA, a Japan-based manufacturer of precision instruments for measurement and analysis, introduced the automated hematology analyzers Yumizen H550E, H500E CT and Yumizen H500E OT, compact hematology analyzers. It is designed to integrate Erythrocyte Sedimentation Rate (ESR) testing with Complete Blood Count/Differential (CBC/DIFF) analysis. These analyzers deliver rapid results in just 60 seconds, enhancing operational efficiency and reducing costs for small to mid-throughput laboratories. Equipped with advanced connectivity through the Yumizen P8000 middleware and AI-driven infectious disease screening capabilities, these versatile analyzers are well-suited for a range of clinical applications, including oncology, infectious disease management and critical care settings.

Opportunities And Recommendations In The Automated Analyzers Market

Opportunities –Recommendations- - To take advantage of the opportunities, The Business Research Company recommends the automated analyzers focus on developing high-throughput smart analyzers with laboratory integration, focus on smart, connected automated analyzers, focus on advancing space-saving cartridge technology for faster diagnoses, focus on advancing real-time PCR technology for syndromic testing, focus on next-generation CLIA technology for health screening, focus on high-performance analyzers for modern laboratories, expand in emerging markets, continue to focus on developed markets, focus on expanding distribution channels for automated analyzers, focus on strategic pricing for automated analyzers, focus on targeted digital marketing strategies, focus on strategic partnerships and industry events, focus on targeting diagnostic laboratories in the automated analyzers market.